Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 731

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 731
---
                        |     | $ | (9,684,466 | ) |     | $ | (13,879,371 | ) |
| Net cash used in investing activities                        |     |   |          — |   |     |   |           — |   |
| Net cash provided by financing activities                    |     | $ |  1,633,746 |   |     | $ |  17,396,669 |   |
| Effect of exchange rate changes on cash and cash equivalents |     |   |          — |   |     |   |        (100 | ) |
| Net increase (decrease) in cash and cash equivalents         |     | $ | (8,050,720 | ) |     | $ |   3,517,198 |   |

Operating Activities Net cash used in operating activities was $9,684,466 during the year ended December 31, 2023 compared with net cash used in operating activities of $13,879,371 for the year ended December 31, 2022. The change in cash used in operating activities for the year ended December 31, 2023 was due to our reporting a net loss of $11,807,063 for the year ended December 31, 2023, compared with a net loss of $15,985,002 for the same period in 2022, driven by a $3,068,355 decrease in research and development costs for the year ended December 31, 2023. Until we can generate significant recurring revenues, we expect to satisfy our future cash needs through debt and/or equity financings. We cannot be certain that additional funding will be available to us on acceptable terms, if at all. This may raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. If funds are not available, we may be required to delay, reduce the scope of, or eliminate research or development plans for, or commercialization efforts with respect to our product candidates. Investing Activities We had no net cash from or used in investing activities in 2023 or 2022. Financing Activities Net cash provided by financing activities of $1,633,746 for the year ended December 31, 2023, consisted of $1,633,746 of net proceeds from short -termloan agreements with certain existing shareholders of the Company.

Annex F-81 Net cash provided by financing activities of $